• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用供血者血液鸟嘌呤酶活性筛查试验预防输血后非甲非乙型肝炎

Prevention of posttransfusional non-A, non-B hepatitis using the screening test for guanase activity of donor blood.

作者信息

Ito S, Tsuji Y

机构信息

Second Department of Internal Medicine, School of Medicine, University of Tokushima, Japan.

出版信息

Gastroenterol Jpn. 1988 Apr;23(2):153-9. doi: 10.1007/BF02799027.

DOI:10.1007/BF02799027
PMID:3133278
Abstract

A total of 107 recipients, who did not show any evidence of hepatic disorders in pretransfusional liver function tests and gave a negative reaction for HBsAg, were observed from 3 weeks to 3 months after blood transfusion of 711 units of blood. Of 107 recipients, 18 (17%) developed posttransfusional non-A, non-B hepatitis (PTH). It was detected in 2 of 71 recipients (3%) with blood guanase activities below 3.5 U/L and in 16 of 36 recipients (44%) with blood guanase activities above 3.6 U/L. It is considered that development of PTH could be reduced by avoiding use of donor blood with high guanase activity. We adopted an automated method for measuring guanase in donor blood in the Tokushima Red Cross blood center and examined the incidence of PTH when donor blood with high guanase activity was excluded. Of 112 recipients, 8 (7%) developed PTH. The incidence of PTH was 17% before adoption of the guanase screening test and 7% after its adoption. This work shows that for prevention of PTH it is very important to screen donor blood for guanase activity and discard blood with high guanase activity.

摘要

共有107名受血者,他们在输血前肝功能检查中未显示任何肝脏疾病迹象,且乙肝表面抗原(HBsAg)检测呈阴性,在输注711单位血液后的3周内至3个月期间接受了观察。在这107名受血者中,18人(17%)发生了输血后非甲非乙型肝炎(PTH)。在71名血鸟氨酸酶活性低于3.5 U/L的受血者中有2人(3%)检测出该病,而在36名血鸟氨酸酶活性高于3.6 U/L的受血者中有16人(44%)检测出该病。据认为,通过避免使用鸟氨酸酶活性高的供血,可降低PTH的发生率。我们在德岛红十字血液中心采用了一种自动方法来检测供血中的鸟氨酸酶,并在排除鸟氨酸酶活性高的供血后检查了PTH的发生率。在112名受血者中,8人(7%)发生了PTH。在采用鸟氨酸酶筛查试验之前,PTH的发生率为17%,采用之后为7%。这项工作表明,为预防PTH,对供血进行鸟氨酸酶活性筛查并丢弃鸟氨酸酶活性高的血液非常重要。

相似文献

1
Prevention of posttransfusional non-A, non-B hepatitis using the screening test for guanase activity of donor blood.采用供血者血液鸟嘌呤酶活性筛查试验预防输血后非甲非乙型肝炎
Gastroenterol Jpn. 1988 Apr;23(2):153-9. doi: 10.1007/BF02799027.
2
Clinical value of the guanase screening test in donor blood for prevention of posttransfusional non-A, non-B hepatitis.供体血液中鸟嘌呤酶筛查试验在预防输血后非甲非乙型肝炎中的临床价值。
Hepatology. 1988 Mar-Apr;8(2):383-4. doi: 10.1002/hep.1840080233.
3
Relationship between guanase activity in donor blood and the incidence of posttransfusional non-A, non-B hepatitis, and a possible method for preventing posttransfusional hepatitis.供血者血液中鸟嘌呤酶活性与输血后非甲非乙型肝炎发病率的关系及预防输血后肝炎的一种可能方法。
Hepatology. 1986 Sep-Oct;6(5):990-3. doi: 10.1002/hep.1840060530.
4
Guanase activity in the donor serum and the incidence of posttransfusion hepatitis non-A, non-B.供体血清中的鸟嘌呤酶活性与非甲非乙型输血后肝炎的发生率
Ann Acad Med Singap. 1986 Apr;15(2):215-20.
5
[The relationship between the guanase activity of donor and incidence of posttransfusion hepatitis].[供血者鸟嘌呤酶活性与输血后肝炎发病率的关系]
Nihon Shokakibyo Gakkai Zasshi. 1985 Feb;82(2):337.
6
[Measurement of serum guanase activity and prevention of non-A, non-B hepatitis].[血清鸟嘌呤酶活性的测定及非甲非乙型肝炎的预防]
Nihon Rinsho. 1984 Mar;42(3):740-53.
7
[The prevention of post-transfusional hepatitis using measurement of guanase activity].[通过测定鸟嘌呤酶活性预防输血后肝炎]
Nihon Shokakibyo Gakkai Zasshi. 1986 Oct;83(10):2266.
8
Prevention of posttransfusional non-A, non-B hepatitis by a screening test for hepatitis C virus antibody of donor bloods.通过检测供血者血液中的丙型肝炎病毒抗体筛查试验预防输血后非甲非乙型肝炎。
Tokushima J Exp Med. 1991 Jun;38(1-2):19-23.
9
Clinical significance of serum guanase activity in various liver diseases.血清鸟嘌呤酶活性在各种肝脏疾病中的临床意义。
Jpn J Med. 1989 Jan-Feb;28(1):22-4. doi: 10.2169/internalmedicine1962.28.22.
10
Clinical evaluation of serum guanase activity in liver diseases.肝脏疾病中血清鸟嘌呤酶活性的临床评估
Clin Biochem. 1984 Oct;17(5):327-30. doi: 10.1016/s0009-9120(84)90661-1.

本文引用的文献

1
Deamination of 8-azaguanine by guanase.鸟嘌呤酶对8-氮杂鸟嘌呤的脱氨基作用。
Arch Biochem. 1950 Nov;29(1):124-9.
2
SERUM GUANASE DETERMINATION: A LIVER-FUNCTION TEST.血清鸟嘌呤酶测定:一项肝功能测试。
J Lab Clin Med. 1965 Feb;65:355-60.
3
A sensitive new method for measurement of guanase with 8-azaguanine in bicine bis-hydroxy ethyl glycine buffer as substrate.一种灵敏的新方法,用于以双(羟乙基)甘氨酸缓冲液中的8-氮杂鸟嘌呤为底物测定鸟嘌呤酶。
Clin Chim Acta. 1981 Sep 10;115(2):135-44. doi: 10.1016/0009-8981(81)90069-3.
4
Clinical and experimental studies of the determination of serum guanase activity in acute myocardial infarction.急性心肌梗死时血清鸟嘌呤酶活性测定的临床与实验研究
Jpn Circ J. 1981 May;45(5):525-31. doi: 10.1253/jcj.45.525.
5
A sensitive spectrophotometric assay for guanase activity.一种用于鸟嘌呤酶活性的灵敏分光光度测定法。
Anal Biochem. 1983 Apr 15;130(2):295-301. doi: 10.1016/0003-2697(83)90591-2.
6
Serum alanine aminotransferase of donors in relation to the risk of non-A,non-B hepatitis in recipients: the transfusion-transmitted viruses study.供体血清丙氨酸氨基转移酶与受者非甲非乙型肝炎风险的关系:输血传播病毒研究
N Engl J Med. 1981 Apr 23;304(17):989-94. doi: 10.1056/NEJM198104233041701.
7
Clinical value of the determination of serum guanase activity. Studies on patients and experimental data from mongrel dogs and cultured rat hepatocytes.血清鸟氨酸酶活性测定的临床价值。对患者的研究以及来自杂种犬和培养大鼠肝细胞的实验数据。
Gastroenterology. 1982 Nov;83(5):1102-8.
8
Evaluation of serum guanase as a liver function test.血清鸟嘌呤酶作为肝功能检测指标的评估
Can J Med Technol. 1967 Apr;29(2):60-8.
9
Evaluation of serum guanase in clinical diagnosis.
Am J Gastroenterol. 1970 Sep;54(3):253-66.
10
Serum guanase activity in viral hepatitis and some other hepatic and extrahepatic diseases.病毒性肝炎及其他一些肝脏和肝外疾病中的血清鸟嘌呤酶活性
Enzymologia. 1970 Jun 30;38(6):373-82.